Search

You searched for "ocular"

1905 results found

Hidden eyelid laceration following blunt trauma

3 April 2024 | | EYE - Oculoplastic, EYE - Cornea, EYE - General
A paediatric case report of a hidden eyelid laceration following blunt trauma. Blunt injury to the eyelid can result in a multitude of issues, such as damage to the eyelid margin, lacrimal system and surrounding orbit [1]. These can often...

Shedding light on Wolfram syndrome: The unveiling of a delayed diagnosis

12 August 2025 | | EYE - Neuro-ophthalmology
Wolfram syndrome 1 (WS1) was first described by Wolfram and Wagener in 1938 and it’s a rare neurodegenerative, progressive disorder, also known as DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness) [1]. We present an atypical case of WS...

A window to 2024 and beyond?

3 April 2024 | | EYE - Cornea
The connection between the eye and systemic diseases has been acknowledged for millenia. Historical records suggest that ancient civilisations had some understanding of the eye’s significance beyond its primary function in vision. For instance, in ancient Egypt, the ‘Eye of...
British Journal of Ophthalmology cover image.

Injection frequency and anatomic outcomes following conversion to Aflibercept in neovascular AMD patients

1 December 2014 | | EYE - Vitreo-Retinal
This is a retrospective study of patients with neovascular age-related macular degeneration (AMD) treated with intravitreal Lucentis and / or Avastin who were switched to aflibercept (Eylea). This study was carried out by the Casey Eye Institute retinal clinics, between...
Ophthalmologica journal cover image

OCTA in diabetic macular oedema treated with intravitreal aflibercept (DOCTA Study)

3 April 2024 | | EYE - Vitreo-Retinal
Central vision loss due to diabetic macular oedema (DME) can be attributed not only to presence of the macular oedema itself but also, in some cases, to alterations of the foveal avascular zone (FAZ). The DOCTA trial was a longitudinal,...

A career in uveitis

7 December 2020 | | EYE - Vitreo-Retinal, EYE - General
As he retires from clinical practice, the author looks back on his long career in uveitis and how care of these patients has changed dramatically since his days as an undergraduate. My trainees and fellows are often bored by my...

My top five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - Vitreo-Retinal
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

My Top Five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - General
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

High-stakes scenarios in retinal vein occlusion: A survey of medico-legal implications

2 October 2025 | | EYE - Vitreo-Retinal, EYE - Glaucoma
Central retinal vein occlusion (CRVO) is the second most common retinal vascular disease after diabetic retinopathy, and its clinical complexity often intersects with medico-legal scrutiny [1]. Missteps in timely diagnosis, inadequate follow-up or poor documentation can lead to patient harm...

Medical Ophthalmological Society (MOSUK) Meeting: 22 March 2023

11 January 2023 |
This year’s meeting takes place on 22 March 2023, and showcases the interdisciplinary breadth of medical ophthalmology.

BHVI Launches Myopia Awareness Week 2023

9 May 2023 | myopia, BHVI, Children
BHVI, an Australian not-for-profit organisation with an international focus on vision research, has announced today the launch of Myopia Awareness Week for 2023 – a global initiative relaunched in 2021, to bring attention to the growing epidemic of myopia in children across the world.

2023 International Myopia Institute White Papers Released in Special Edition of IOVS

9 May 2023 | myopia, White Papers, IMI, IOVS
The International Myopia Institute (IMI) is excited to announce the release of the third series of their highly cited White Papers in a special issue of the top peer-reviewed Investigative Ophthalmology and Visual Science (IOVS) journal.